A drug that curbs delusions in Parkinson’s patients did the same for people with Alzheimer’s disease and other forms of dementia in a clinical trial that was stopped early because the benefit seemed clear. The daily pill targets some of the most troubling symptoms that patients and caregivers face — hallucinations that often lead to anxiety, aggression, and physical and verbal abuse. Advertisement“This would be a very important advance,” said one independent expert, Dr. Howard Fillit, chief science officer of the Alzheimer’s Drug Discovery Foundation. Those are the three most common false beliefs.”Cummings consults for Acadia and helped lead the study, which included about 400 people with dementia and psychosis. Current anti-psychotic medicines have some major drawbacks and are not approved for dementia patients.

Source: Los Angeles Times December 05, 2019 19:07 UTC